Loading…
Cian Healthcare (BSE 542678)₹37.68+4.00%Pharmaceuticals
At the end of the Mar 2026 quarter, Cian Healthcare's shareholders were: promoters 95.01%, public 4.99%. Promoter holding is up 67.89 percentage points from 27.12% a quarter earlier. 0.00% of promoter shares were pledged. It had 1,684 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 49.63% | 27.11% | 27.11% | 27.12% | 27.12% | 27.12% | 95.01% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 50.37% | 72.89% | 72.89% | 72.88% | 72.88% | 72.88% | 4.99% |
| Promoter shares pledged | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 673 | 881 | 832 | 1,089 | 1,502 | 1,663 | 1,684 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Ananta Medicare Limited | Promoter | 55.01% | — |
| Rajesh Jain | Promoter | 20.94% | — |
| Pradeep Kumar Jain | Promoter | 19.04% | — |
Promoters held 95.01% of Cian Healthcare at the end of the Mar 2026 quarter, up 67.90 percentage points from 27.11% a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.00% (unchanged at 0.00% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Cian Healthcare had 1,684 shareholders at the end of the Mar 2026 quarter, against 832 a year earlier.